Octagon Research - Request Participation

Document ID: FDA-2008-N-0428-0004
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: November 14 2008, at 12:26 PM Eastern Standard Time
Date Posted: November 17 2008, at 12:00 AM Eastern Standard Time
Comment Start Date: August 19 2008, at 12:00 AM Eastern Standard Time
Comment Due Date: November 17 2008, at 11:59 PM Eastern Standard Time
Tracking Number: 807a9a8b
View Document:  View as format xml

View Comment

Octagon Research would like to participate in the Phase 3 Janus Pilot project. We are currently preparing over 10 projects for submission in the SDTM format within the next year to the FDA. Octagon would like to be actively involved with the agency to ensure proper validation of the submitted data to provide accurate loading and processing by the Janus system. Octagon is currently involved in providing CDISC SDTM training to the agency and the industry and would incorporate any knowledge we gain through participating in this pilot into better educating both reviewers and sponsors on the requirements of electronically submitted regulatory data.

Related Comments

   
Total: 4
Novartis Pharmaceuticals Corporation - Request Participation
Public Submission    Posted: 11/17/2008     ID: FDA-2008-N-0428-0002

Nov 17,2008 11:59 PM ET
Octagon Research - Request Participation
Public Submission    Posted: 11/17/2008     ID: FDA-2008-N-0428-0004

Nov 17,2008 11:59 PM ET
Merck & Co., Inc. - Request Participation
Public Submission    Posted: 11/17/2008     ID: FDA-2008-N-0428-0005

Nov 17,2008 11:59 PM ET
Pfizer - Request Participation
Public Submission    Posted: 11/21/2008     ID: FDA-2008-N-0428-0006

Nov 17,2008 11:59 PM ET